Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
George Fountzilas, Urania Dafni, Mattheos Bobos, Vassiliki Kotoula…Том:
13
Мова:
english
DOI:
10.1186/1471-2407-13-163
Date:
December, 2013
Файл:
PDF, 1.92 MB
english, 2013
File converter
Більше результатів пошуку
More benefits 
